Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse Regimen on MGI, PI and BOP

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects are between the ages of 18 to 80 years~* Subjects have a minimum of 20 permanent teeth, excluding third molars~* Subjects have been diagnosed with gingivitis or periodontitis (Stages I and II are based on the level of CAL and Bone Loss (BL). The diagnosis is Stage I if: (a) BL is less than 15% and (b) CAL is between 1-2mm. The diagnosis is Stage II if: (a) BL is between 15% and 33% and (b) CAL is between 3-4mm)~* Subjects exhibit bleeding upon probing in \>20% of sites~* Subject is seen every 3 months for routine dental prophylaxis/periodontal maintenance~* Subjects do not have a significant medical history or metabolic diseases (diabetes with A1C ≥ 7.0, pregnancy)~* Subject is currently a non-smoker or has discontinued smoking at least 6 months prior to enrollment~* Subject agrees to refrain from use of the following products: Peridex®, PerioGuard®, Listerine®, Cepacol®, Crest Pro-Health® rinse, Colgate Total® rinse, Colgate Total® toothpaste, Crest Pro Health® toothpaste, or any generic equivalent while participating in this study. Alcohol is not the active ingredient in any oral rinse product and does not produce a significant antibacterial effect~* Subject is able to read and provide written informed consent~* Subject is able to follow verbal and/or written instructions, perform oral hygiene procedures and return to the test facility for specified study examinations~* Subject agrees not to receive a dental cleaning (prophylaxis) while in the study~* Subject must permanently reside in Arizona~Exclusion Criteria:~* Subject has significant medical history or poorly controlled/uncontrolled diabetes (as defined above)~* Subject is pregnant~* Subject has a medical condition that requires antibiotic premedication prior to dental treatment~* Subject has taken antibiotics within 1 month of study enrollment~* Subject who takes multiple medications and/or herbal and dietary supplements known to alter bleeding and exhibits/reports spontaneous gingival bleeding~* Subject takes medications that may interfere with study results (eg. antibiotics, steroids, immunosuppressants, high dose aspirin (325+ mg/day), chemotherapy and/or radiation therapy for cancer).~* Subject is a current smoker~* Subject has a history of non-surgical or surgical periodontal therapy within 6 months of study participation~* Subject has Stage III or IV periodontitis, Grade B or C~* Subject is currently taking or in the past 28 days has taken another investigational drug or participated in other investigational studies that may impact study outcomes~* Subject has not had a dental cleaning within six months prior to the start of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Group (Type: EXPERIMENTAL): Participants with gingivitis or periodontitis (Stage I or II) brush with ClōSYS® Sensitive Fluoride Toothpaste twice daily and rinse with ClōSYS® Sensitive Rinse twice daily after brushing.

Based on this trial design, predict the completion outcome and termination type (if applicable).